Nitric Oxide and the Autonomic Nervous System

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
HypertensionPure Autonomic Failure
Interventions
DRUG

L-NMMA

IV infusion of 125, 250 and 500 mcg/Kg/min for 15 minutes each dose. The main outcome is the maximal increase in blood pressure produced at the end of the infusions or a maximal systolic blood pressure of 160 mm Hg. It could be achieved after the first dose or the third.

DRUG

Trimethaphan

IV infusion for the duration of the study at 4-6 mg/min depending on autonomic blockade. This is only to produce transient pharmacological blockade of the autonomic nervous system in order to allow the full expression of the inhibition of nitric oxide synthase. There is no direct outcome associated with this intervention.

Trial Locations (1)

37232

Autonomic Dysfunction Center, Nashville

All Listed Sponsors
lead

Vanderbilt University

OTHER

NCT00178919 - Nitric Oxide and the Autonomic Nervous System | Biotech Hunter | Biotech Hunter